Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04211818Completed
Open-label, single-arm trial, sponsored by CHU Montpellier. Primary endpoint: Frequency of episodes of bulimia according to the interstitial glucose levels at 14 days. Started Oct 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04211818.